Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lars Lind

Showing results (301-310 of 826) with videos related to

Pageof 83
Sort By:
Atherosclerosis|October 9, 2016
The association between serum cathepsin L and mortality in older adultsTobias Feldreich, Axel C Carlsson, Ulf Risérus, et al.
Journal of Sleep Research|March 22, 2021
Sleep duration is associated with protein biomarkers for cardiometabolic health: A large-scale population studyJenny Theorell-Haglöw, Ulf Hammar, Lars Lind, et al.
European Journal of Preventive Cardiology|January 22, 2015
Physical activity, obesity and risk of cardiovascular disease in middle-aged men during a median of 30 years of follow-upAxel C Carlsson, Johan Ärnlöv, Johan Sundström, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|May 25, 2025
Combinations of BMI and metabolic syndrome and the risk of myocardial infarction, stroke, and heart failureLars Lind, Ulf Risérus, Sölve Elmståhl, et al.
Atherosclerosis|March 12, 2013
Total atherosclerotic burden by whole body magnetic resonance angiography predicts major adverse cardiovascular eventsChristina Lundberg, Lars Johansson, Charlotte Ebeling Barbier, et al.
Metabolic Syndrome and Related Disorders|September 6, 2018
Can the Plasma Concentration Ratio of Triglyceride/High-Density Lipoprotein Cholesterol Identify Individuals at High Risk of Cardiovascular Disease During 40-Year Follow-Up?Lars Lind, Erik Ingelsson, Johan Ärnlöv, et al.
Environmental Research|March 1, 2022
Changes in plasma levels of per- and polyfluoroalkyl substances (PFAS) are associated with changes in plasma lipids - A longitudinal study over 10 yearsLinda Dunder, P Monica Lind, Samira Salihovic, et al.
Environment International|October 13, 2023
Plasma levels of per- and polyfluoroalkyl substances (PFAS) and cardiovascular disease - Results from two independent population-based cohorts and a meta-analysisLinda Dunder, Samira Salihovic, Georgios Varotsis, et al.
Neurobiology of Aging|July 28, 2016
Association between shift work history and performance on the trail making test in middle-aged and elderly humans: the EpiHealth studyOlga E Titova, Eva Lindberg, Sölve Elmståhl, et al.
Diabetes|October 1, 2015
Protein Biomarkers for Insulin Resistance and Type 2 Diabetes Risk in Two Large Community CohortsChristoph Nowak, Johan Sundström, Stefan Gustafsson, et al.
Pageof 83

Showing results (301-310 of 826) with videos related to

Sort By:
Pageof 83
Atherosclerosis|October 9, 2016
The association between serum cathepsin L and mortality in older adultsTobias Feldreich, Axel C Carlsson, Ulf Risérus, et al.
Journal of Sleep Research|March 22, 2021
Sleep duration is associated with protein biomarkers for cardiometabolic health: A large-scale population studyJenny Theorell-Haglöw, Ulf Hammar, Lars Lind, et al.
European Journal of Preventive Cardiology|January 22, 2015
Physical activity, obesity and risk of cardiovascular disease in middle-aged men during a median of 30 years of follow-upAxel C Carlsson, Johan Ärnlöv, Johan Sundström, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|May 25, 2025
Combinations of BMI and metabolic syndrome and the risk of myocardial infarction, stroke, and heart failureLars Lind, Ulf Risérus, Sölve Elmståhl, et al.
Atherosclerosis|March 12, 2013
Total atherosclerotic burden by whole body magnetic resonance angiography predicts major adverse cardiovascular eventsChristina Lundberg, Lars Johansson, Charlotte Ebeling Barbier, et al.
Metabolic Syndrome and Related Disorders|September 6, 2018
Can the Plasma Concentration Ratio of Triglyceride/High-Density Lipoprotein Cholesterol Identify Individuals at High Risk of Cardiovascular Disease During 40-Year Follow-Up?Lars Lind, Erik Ingelsson, Johan Ärnlöv, et al.
Environmental Research|March 1, 2022
Changes in plasma levels of per- and polyfluoroalkyl substances (PFAS) are associated with changes in plasma lipids - A longitudinal study over 10 yearsLinda Dunder, P Monica Lind, Samira Salihovic, et al.
Environment International|October 13, 2023
Plasma levels of per- and polyfluoroalkyl substances (PFAS) and cardiovascular disease - Results from two independent population-based cohorts and a meta-analysisLinda Dunder, Samira Salihovic, Georgios Varotsis, et al.
Neurobiology of Aging|July 28, 2016
Association between shift work history and performance on the trail making test in middle-aged and elderly humans: the EpiHealth studyOlga E Titova, Eva Lindberg, Sölve Elmståhl, et al.
Diabetes|October 1, 2015
Protein Biomarkers for Insulin Resistance and Type 2 Diabetes Risk in Two Large Community CohortsChristoph Nowak, Johan Sundström, Stefan Gustafsson, et al.
Pageof 83